SQI Q4 Net Loss Jumps 50 Percent on Professional Fees | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SQI Diagnostics reported after the close of the market Wednesday that its fourth-quarter 2011 net loss climbed 50 percent on higher professional and consulting fees tied to an acquisition that was not completed and financings.

The Toronto-based microarray diagnostics firm reported revenues of C$5,000 (US$4,884) for the quarter ended Sept. 30, compared to C$14,000 for the fourth quarter of 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.